SMS Lifesciences India (BOM:540679) Long-Term Capital Lease Obligation : ₹24 Mil (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is SMS Lifesciences India Long-Term Capital Lease Obligation?

SMS Lifesciences India's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹24 Mil.

SMS Lifesciences India's quarterly Long-Term Capital Lease Obligation declined from Sep. 2023 (₹10 Mil) to Dec. 2023 (₹0 Mil) but then increased from Dec. 2023 (₹0 Mil) to Mar. 2024 (₹24 Mil).

SMS Lifesciences India's annual Long-Term Capital Lease Obligation declined from Mar. 2022 (₹19 Mil) to Mar. 2023 (₹13 Mil) but then increased from Mar. 2023 (₹13 Mil) to Mar. 2024 (₹24 Mil).

SMS Lifesciences India Long-Term Capital Lease Obligation Historical Data

The historical data trend for SMS Lifesciences India's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SMS Lifesciences India Long-Term Capital Lease Obligation Chart

SMS Lifesciences India Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

9.89

18.53

13.05

23.94

SMS Lifesciences India Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															13.05	-	9.76	-	23.94

SMS Lifesciences India (BOM:540679) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

SMS Lifesciences India Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of SMS Lifesciences India's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

SMS Lifesciences India (BOM:540679) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SMS Lifesciences India Ltd (BOM:540679) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

SMSLIFE:India

Address

Road Number 71, Plot Number 19 - III, Opposite Bharatiya Vidya Bhavan Public School, Jubilee Hills, Hyderabad, TG, IND, 500096

Website

https://www.smslife.in

SMS Lifesciences India Ltd is engaged in the Business of manufacturing of Active Pharmaceutical Ingredients (APIs) and its intermediates and sells its products in India as well as exports. The group sells its products in India and also exports it to other countries. Some of its API products are used in therapy as an Antiulcer, Antifungal, and Erectile Dysfunction.

SMS Lifesciences India (BOM:540679) Headlines

No Headlines